FY2024 EPS Estimates for Globus Medical Reduced by Analyst
Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a ...
RBC Capital Keeps Their Buy Rating on ARB Corporation Limited (ARBFF)
RBC Capital analyst Jack Lynch maintained a Buy rating on ARB Corporation Limited (ARBFF – Research Report) on January 29 and set a price ...
RBC Capital Reaffirms Their Buy Rating on Greencoat UK Wind (UKW)
RBC Capital analyst Alexander Wheeler maintained a Buy rating on Greencoat UK Wind (UKW – Research Report) on January 29 and set a price target ...
Financial Services Roundup: Market Talk
Find insight on Blackstone, BBVA, CaixaBank, Assicurazioni Generali and more in the latest Market Talks covering financial ...
bovnews16h
RBC Capital Mkts Issues Outperform Rating for Sandstorm Gold Ltd (SAND) Stock
RBC Capital Mkts has recently raised Sandstorm Gold Ltd (SAND) stock to Outperform rating, as announced on March 2, 2023, according to Finviz. Earlier, on October 5, 2022, BMO Cap ...
Sarepta could be down on patient death in FDA database, says RBC Capital
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
Biggest of the Big Six: How RBC opened a $100-billion market-cap gap over its banking rivals
J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...
RBC lifts Meta Platforms stock target to $800 on AI prospects
RBC Capital Markets adjusted its outlook on Meta Platforms Inc. (NASDAQ: NASDAQ:META), increasing the price target to $800 from the previous $700 while maintaining an Outperform rating on the stock.